Project overview Joint Funding
Boost-CAR (Enhancing CAR T-Cell Therapy through Metabolic CAR-T Engineering and Tumor Microenvironment Reprogramming)
Program: Therapeutic Innovations Funding Line: Joint Funding 2025 onwards Project type: research project Entity: blood cancer Status: current
A project description will be provided
Involved Partnersites
Essen/Dusseldorf, Frankfurt/Mainz, MunichCoordinators
